Investor Relations |
|
At Questcor, we are a biopharmaceutical company whose products help patients with serious, difficult-to-treat medical conditions. Our efforts are currently focused on the fields of neurology and nephrology, areas of medicine which have significant unmet medical needs.
Recent Releases
Jan 16, 2012
Questcor Pharmaceuticals Responds to Questions From Investor Blog
Jan 11, 2012
Questcor Pharmaceuticals Issues Statement
Jan 6, 2012
Questcor Pharmaceuticals Reports Strong Finish to 2011
Events & Presentations
Jan 12, 2012 at 10:00 AM PT
Questcor Pharmaceuticals Presents at the 30th Annual J.P. Morgan Healthcare Conference
Dec 13, 2011 at 2:45 PM ET
Questcor Presents at the Oppenheimer Healthcare Conference
| Investor Presentation |
|---|
 |
| Stock Chart | |
|---|---|
|
|
|
| Stock Quote | |
| Questcor Pharmaceuticals, Inc. | |
| Price: | 36.48 |
| Change: | + 0.49 |
| Day High: | 38.34 |
| Day Low: | 35.71 |
| Volume: | 3,383,700 |
| Delayed at least 20 minutes. Provided by eSignal. |
|
Transfer Agent
Computershare Trust Co., Inc.Phone 303-262-0600
Corporate Counsel
Stradling Yocca Carlson & RauthNewport Beach, CA
Independent Accountants
BDO USA, LLPInvestor Relations Contacts
Doug Sherk, EVC Group, 415-896-6820or
Tracy Megee, (714) 786-4205